Oral and nasal probiotic administration for the prevention and alleviation of allergic diseases, asthma and chronic obstructive pulmonary disease
- 13 April 2020
- journal article
- review article
- Published by Cambridge University Press (CUP) in Nutrition Research Reviews
- Vol. 34 (1), 1-16
- https://doi.org/10.1017/s0954422420000116
Abstract
Interaction between a healthy microbiome and the immune system leads to body homeostasis, as dysbiosis in microbiome content and loss of diversity may result in disease development. Due to the ability of probiotics to help and modify microbiome constitution, probiotics are now widely used for the prevention and treatment of different gastrointestinal, inflammatory, and, more recently, respiratory diseases. In this regard, chronic respiratory diseases including chronic obstructive pulmonary disease (COPD), asthma and allergic rhinitis are among the most common and complicated respiratory diseases with no specific treatment until now. Accordingly, many studies have evaluated the therapeutic efficacy of probiotic administration (mostly via the oral route and much lesser nasal route) on chronic respiratory diseases. We tried to summarise and evaluate these studies to give a perspective of probiotic therapy via both the oral and nasal routes for respiratory infections (in general) and chronic respiratory diseases (specifically). We finally concluded that probiotics might be useful for allergic diseases. For asthmatic patients, probiotics can modulate serum cytokines and IgE and decrease eosinophilia, but with no significant reduction in clinical symptoms. For COPD, only limited studies were found with uncertain clinical efficacy. For intranasal administration, although some studies propose more efficiency than the oral route, more clinical evaluations are warranted.Keywords
This publication has 113 references indexed in Scilit:
- Probiotics in the Management of Lung DiseasesMediators of Inflammation, 2013
- Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in miceInternational Immunopharmacology, 2010
- Comparative Analyses of the Bacterial Microbiota of the Human Nostril and OropharynxmBio, 2010
- Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newbornsProceedings of the National Academy of Sciences of the United States of America, 2010
- Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responsesLetters in Applied Microbiology, 2010
- The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an updateClinical and Experimental Immunology, 2010
- A Persistent and Diverse Airway Microbiota Present during Chronic Obstructive Pulmonary Disease ExacerbationsOMICS: A Journal of Integrative Biology, 2010
- COPD diagnosis related to different guidelines and spirometry techniquesRespiratory Research, 2007
- Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagementThe Journal of Experimental Medicine, 2006
- Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and DiseasePhysiological Reviews, 2006